Giampietro Corradin

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


251 publications

2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | ...
2022
Randomized clinical trial to assess the protective efficacy of a Plasmodium vivax CS synthetic vaccine.
Arévalo-Herrera M., Gaitán X., Larmat-Delgado M., Caicedo M.A., Herrera S.M., Henao-Giraldo J., Castellanos A., Devaud J.C., Pannatier A., Oñate J. et al., 2022/03/25. Nature communications, 13 (1) p. 1603. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D09811DF074D]
 
Immunogenicity of full-length P. vivax rPvs48/45 protein formulations in BALB/c mice.
Arévalo-Herrera M., Miura K., Solano E., Sebastián Ramírez J., Long C.A., Corradin G., Herrera S., 2022/01/03. Vaccine, 40 (1) pp. 133-140. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_58B142EF41E8]
 
A SARS-CoV-2 Spike Receptor Binding Motif Peptide Induces Anti-Spike Antibodies in Mice andIs Recognized by COVID-19 Patients.
Pratesi F., Errante F., Pacini L., Peña-Moreno I.C., Quiceno S., Carotenuto A., Balam S., Konaté D., Diakité M.M., Arévalo-Herrera M. et al., 2022. Frontiers in immunology, 13 p. 879946. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3F48A4BC6061]
 
Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas.
Traoré A., Guindo M.A., Konaté D., Traoré B., Diakité S.A., Kanté S., Dembélé A., Cissé A., Incandela N.C., Kodio M. et al., 2022. Frontiers in immunology, 13 p. 856033. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CD6A1BC5B8B6]
2021
 
Nanotechnological immunoassay for rapid label-free analysis of candidate malaria vaccines.
Brunetti G., Padovani F., De Pastina A., Rotella C., Monahan A., Hoffman S.L., Jongo S.A., Abdulla S., Corradin G., Pluschke G. et al., 2021/02/04. Nanoscale, 13 (4) pp. 2338-2349. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0654E4F1C612]
 
Immunoreactivity of Sera From Low to Moderate Malaria-Endemic Areas Against Plasmodium vivax rPvs48/45 Proteins Produced in Escherichia coli and Chinese Hamster Ovary Systems.
Arévalo-Herrera M., Miura K., Cespedes N., Echeverry C., Solano E., Castellanos A., Ramirez J.S., Miranda A., Kajava A.V., Long C. et al., 2021. Frontiers in immunology, 12 p. 634738. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C2828818013D]
2020
Trimeric SARS-CoV-2 Spike Proteins Produced from CHO Cells in Bioreactors Are High-Quality Antigens
Pino Paco, Kint Joeri, Kiseljak Divor, Agnolon Valentina, Corradin Giampietro, Kajava Andrey V., Rovero Paolo, Dijkman Ronald, den Hartog Gerco, McLellan Jason S. et al., 2020/11/25. Processes, 8 (12) p. 1539.
[URN][DOI][WoS][serval:BIB_E313FE209395]
 
Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity.
Agnolon V., Kiseljak D., Wurm M.J., Wurm F.M., Foissard C., Gallais F., Wehrle S., Muñoz-Fontela C., Bellanger L., Correia B.E. et al., 2020. Frontiers in immunology, 11 p. 586595. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AD44132F37DC]
 
Epitope Mapping and Fine Specificity of Human T and B Cell Responses for Novel Candidate Blood-Stage Malaria Vaccine P27A.
Geiger K.M., Guignard D., Yang C., Bikorimana J.P., Correia B.E., Houard S., Mkindi C., Daubenberger C.A., Spertini F., Corradin G. et al., 2020. Frontiers in immunology, 11 p. 412. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_941F355259B5]
 
P. falciparum and P. vivax Orthologous Coiled-Coil Candidates for a Potential Cross-Protective Vaccine.
Ayadi I., Balam S., Audran R., Bikorimana J.P., Nebie I., Diakité M., Felger I., Tanner M., Spertini F., Corradin G. et al., 2020. Frontiers in immunology, 11 p. 574330. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_00B3708CAEEE]
2019
 
Immunogenicity of a recombinant fusion construct composed of intrinsically unstructured, low polymorphic segments derived from merozoite surface protein 2 and trophozoite exported protein 1.
Tiendrebeogo R.W., Spallek R., Oehlmann W., Singh M., Theisen M., Nebie I., Moret R., Roussilhon C., Corradin G., 2019/08/23. Vaccine, 37 (36) pp. 5332-5340. Peer-reviewed.
[DOI][Pmid][serval:BIB_037D9651CD52]
Detection of antisense protein (ASP) RNA transcripts in individuals infected with human immunodeficiency virus type 1 (HIV-1).
Mancarella A., Procopio F.A., Achsel T., De Crignis E., Foley B.T., Corradin G., Bagni C., Pantaleo G., Graziosi C., 2019/05. The Journal of general virology, 100 (5) pp. 863-876. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4178D396A6C4]
2018
A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein.
Tan J., Sack B.K., Oyen D., Zenklusen I., Piccoli L., Barbieri S., Foglierini M., Fregni C.S., Marcandalli J., Jongo S. et al., 2018. Nature Medicine, 24 (4) pp. 401-407. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DC5884589CC7]
2017
Natural immune response to Plasmodium vivax alpha-helical coiled coil protein motifs and its association with the risk of P. vivax malaria.
Céspedes N., Li Wai Suen CSN, Koepfli C., França C.T., Felger I., Nebie I., Arévalo-Herrera M., Mueller I., Corradin G., Herrera S., 2017. PLoS One, 12 (6) pp. e0179863. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_477CA6563B17]
The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria.
Karch C.P., Doll TAPF, Paulillo S.M., Nebie I., Lanar D.E., Corradin G., Burkhard P., 2017. Journal of Nanobiotechnology, 15 (1) p. 62. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7E125AC41CC4]
2016
Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas.
Adu B., Cherif M.K., Bosomprah S., Diarra A., Arthur F.K., Dickson E.K., Corradin G., Cavanagh D.R., Theisen M., Sirima S.B. et al., 2016. Malaria Journal, 15 p. 123. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A628095CF2EF]
 
Immunogenicity of dimorphic and C-terminal fragments of Plasmodium falciparum MSP2 formulated with different adjuvants in mice.
Balam S., Jafarshad A., Servis C., Frank G., Reed S., Pink R., Druilhe P., Spertini F., Corradin G., 2016. Vaccine, 34 (13) pp. 1566-1574. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_072D0AC9EFBC]
2014
 
Antigenicity and immunogenicity of a novel Plasmodium vivax circumsporozoite derived synthetic vaccine construct.
Céspedes N., Jiménez E., Lopez-Perez M., Rubiano K., Felger I., Alonso P., Arévalo-Herrera M., Corradin G., Herrera S., 2014. Vaccine, 32 (26) pp. 3179-3186.
[DOI][WoS][Pmid][serval:BIB_6A1C4A03C20D]
Malaria Vaccines: Progressing on a Bumpy Road
Corradin G., Nebie I., 2014. Ebiomedicine, 1 (1) pp. 6-7. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7B56340F528B]
Plasmodium falciparum merozoite surface protein 2: epitope mapping and fine specificity of human antibody response against non-polymorphic domains.
Balam S., Olugbile S., Servis C., Diakité M., D'Alessandro A., Frank G., Moret R., Nebie I., Tanner M., Felger I. et al., 2014. Malaria Journal, 13 p. 510.
[URN][DOI][WoS][Pmid][serval:BIB_2CED1904C6D2]
Plasmodium vivax antigen discovery based on alpha-helical coiled coil protein motif.
Céspedes N., Habel C., Lopez-Perez M., Castellanos A., Kajava A.V., Servis C., Felger I., Moret R., Arévalo-Herrera M., Corradin G. et al., 2014. PLoS One, 9 (6) pp. e100440.
[URN][DOI][WoS][Pmid][serval:BIB_4C88603DA7E0]
Priming of CD8 + T Cell Responses to Liver Stage Malaria Parasite Antigens
Corradin G., Levitskaya J., 2014. Frontiers In Immunology, 5 p. 527. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D042D84A81A7]
2013
 
Antigenicity and immunogenicity of a novel chimeric peptide antigen based on the P. vivax circumsporozoite protein.
Céspedes N., Arévalo-Herrera M., Felger I., Reed S., Kajava A.V., Corradin G., Herrera S., 2013. Vaccine, 31 (42) pp. 4923-4930.
[DOI][WoS][Pmid][serval:BIB_4F76CAE46089]
 
Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.
Wetter M., Kowarik M., Steffen M., Carranza P., Corradin G., Wacker M., 2013. Glycoconjugate Journal, 30 (5) pp. 511-522.
[DOI][WoS][Pmid][serval:BIB_2EAF4716E8DF]
Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides.
Pellaton C., Perrin Y., Boudousquié C., Barbier N., Wassenberg J., Corradin G., Thierry A.C., Audran R., Reymond C., Spertini F., 2013. Clinical and Translational Allergy, 3 (1) p. 17.
[URN][DOI][Pmid][serval:BIB_1F03735EDF6D]
2012
Cell biological characterization of the malaria vaccine candidate trophozoite exported protein 1.
Kulangara C., Luedin S., Dietz O., Rusch S., Frank G., Mueller D., Moser M., Kajava A.V., Corradin G., Beck H.P. et al., 2012. PLoS One, 7 (10) pp. e46112.
[URN][DOI][WoS][Pmid][serval:BIB_24FCFF24E8AE]
CSP-A Model for In Vivo Presentation of Plasmodium berghei Sporozoite Antigens by Hepatocytes.
Balam S., Romero J.F., Bongfen S.E., Guillaume P., Corradin G., 2012. PLoS One, 7 (12) pp. e51875.
[URN][DOI][WoS][Pmid][serval:BIB_EC5A0E7527B6]
 
Functional analysis of Plasmodium vivax VIR proteins reveals different subcellular localizations and cytoadherence to the ICAM-1 endothelial receptor.
Bernabeu M., Lopez F.J., Ferrer M., Martin-Jaular L., Razaname A., Corradin G., Maier A.G., Del Portillo H.A., Fernandez-Becerra C., 2012. Cellular Microbiology, 14 (3) pp. 386-400. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D15DEA40915E]
 
Heterologous prime-boost regimen adenovector 35-circumsporozoite protein vaccine/recombinant Bacillus Calmette-Guérin expressing the Plasmodium falciparum circumsporozoite induces enhanced long-term memory immunity in BALB/c mice.
Arama C., Assefaw-Redda Y., Rodriguez A., Fernández C., Corradin G., Kaufmann S.H., Reece S.T., Troye-Blomberg M., 2012. Vaccine, 30 (27) pp. 4040-4045.
[DOI][WoS][Pmid][serval:BIB_B2AC3A3D8304]
 
Malaria vaccine development using synthetic peptides as a technical platform.
Corradin G., Céspedes N., Verdini A., Kajava A.V., Arévalo-Herrera M., Herrera S., 2012. Advances in Immunology, 114 pp. 107-149.
[DOI][WoS][Pmid][serval:BIB_0B9196F7AEB3]
2011
 
Strain-transcending Fc-dependent killing of Plasmodium falciparum by merozoite surface protein 2 allele-specific human antibodies.
Stubbs J., Olugbile S., Saidou B., Simpore J., Corradin G., Lanzavecchia A., 2011/03. Infection and immunity, 79 (3) pp. 1143-1152. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_43E2E39D9B7A]
 
A research agenda for malaria eradication: vaccines.
malERA Consultative Group on Vaccines, 2011. Plos Medicine, 8 (1) pp. e1000398.
[DOI][WoS][Pmid][serval:BIB_17D4358B17E9]
 
Antibody-mediated and cellular immune responses induced in naive volunteers by vaccination with long synthetic peptides derived from the Plasmodium vivax circumsporozoite protein.
Arévalo-Herrera M., Soto L., Perlaza B.L., Céspedes N., Vera O., Lenis A.M., Bonelo A., Corradin G., Herrera S., 2011. American Journal of Tropical Medicine and Hygiene, 84 (2 Suppl) pp. 35-42.
[DOI][WoS][Pmid][serval:BIB_B879968D032D]
Malaria vaccine candidate: design of a multivalent subunit α-helical coiled coil poly-epitope.
Olugbile S., Villard V., Bertholet S., Jafarshad A., Kulangara C., Roussilhon C., Frank G., Agak G.W., Felger I., Nebie I. et al., 2011. Vaccine, 29 (40) pp. 7090-7099.
[URN][DOI][WoS][Pmid][serval:BIB_5B23A6FA2B46]
 
Phase I safety and immunogenicity trial of Plasmodium vivax CS derived long synthetic peptides adjuvanted with montanide ISA 720 or montanide ISA 51.
Herrera S., Fernández O.L., Vera O., Cárdenas W., Ramírez O., Palacios R., Chen-Mok M., Corradin G., Arévalo-Herrera M., 2011. American Journal of Tropical Medicine and Hygiene, 84 (2 Suppl) pp. 12-20.
[DOI][WoS][Pmid][serval:BIB_7EBF877C0A3C]
 
Plasmodium falciparum merozoite surface protein 2: epitope mapping and biological activity analysis of specific antibodies
Balam S., Frank G., Diakite M., Moret R., Corradin G., Spertini F., 2011. p. 103 dans Annual Congress SGAI-SSAI, Advances in immunology and allergology: from research to diagnosis and therapy, Allergologie. Peer-reviewed.
[WoS][serval:BIB_04FA4EB734BE]
 
Preclinical vaccine study of Plasmodium vivax circumsporozoite protein derived-synthetic polypeptides formulated in montanide ISA 720 and montanide ISA 51 adjuvants.
Arévalo-Herrera M., Vera O., Castellanos A., Céspedes N., Soto L., Corradin G., Herrera S., 2011. American Journal of Tropical Medicine and Hygiene, 84 (2 Suppl) pp. 21-27.
[DOI][WoS][Pmid][serval:BIB_B4CC21A0B161]
The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host.
Coppi A., Natarajan R., Pradel G., Bennett B.L., James E.R., Roggero M.A., Corradin G., Persson C., Tewari R., Sinnis P., 2011. Journal of Experimental Medicine, 208 (2) pp. 341-356.
[URN][DOI][WoS][Pmid][serval:BIB_A3DBA5DB7241]
2010
Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC).
Maestre A., Muskus C., Duque V., Agudelo O., Liu P., Takagi A., Ntumngia F.B., Adams J.H., Sim K.L., Hoffman S.L. et al., 2010. PLoS One, 5 (7) pp. e11437. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4F98B6858559]
 
Long synthetic peptides for the production of vaccines and drugs: a technological platform coming of age.
Corradin G., Kajava A.V., Verdini A., 2010. Science Translational Medicine, 2 (50) pp. 50rv3.
[DOI][WoS][Pmid][serval:BIB_D9BBF6510985]
 
Malaria vaccine development: 20 years of hopes, hypes and limited achievements
Verdini A., Olugbile S., Corradin G., Pink R., 2010. pp. 21-42 dans Jirillo E., Brandonisio O. (eds.) Protozoa chap. 3, Bentham eBook.
[serval:BIB_1A33D838458B]
 
Malaria vaccine: why is it taking so long?
Corradin G., Kajava A.V., 2010. Expert Review of Vaccines, 9 (2) pp. 111-114.
[DOI][WoS][Pmid][serval:BIB_8E6E55FF98AB]
 
Malaria vaccines - The long synthetic peptide approach: Technical and conceptual advancements.
Olugbile S., Habel C., Servis C., Spertini F., Verdini A., Corradin G., 2010. Current Opinion in Molecular Therapeutics, 12 (1) pp. 64-76.
[WoS][Pmid][serval:BIB_62BF0B2A0A33]
2009
 
Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
Flueck C., Frank G., Smith T., Jafarshad A., Nebie I., Sirima S.B., Olugbile S., Alonso P., Tanner M., Druilhe P. et al., 2009. Vaccine, 27 (20) pp. 2653-2661. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3E289B151B12]
 
Evidence for multiple B- and T-cell epitopes in Plasmodium falciparum liver-stage antigen 3.
Toure-Balde A., Perlaza B.L., Sauzet J.P., Ndiaye M., Aribot G., Tall A., Sokhna C., Rogier C., Corradin G., Roussilhon C. et al., 2009. Infection and immunity, 77 (3) pp. 1189-1196. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_12D4D598C996]
 
Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge.
Romero J.F., Ciabattini A., Guillaume P., Frank G., Ruggiero P., Pettini E., Del Giudice G., Medaglini D., Corradin G., 2009. Vaccine, 27 (8) pp. 1266-1271. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9E0078FD5F1B]
Malarial hemozoin is a Nalp3 inflammasome activating danger signal.
Dostert C., Guarda G., Romero J.F., Menu P., Gross O., Tardivel A., Suva M.L., Stehle J.C., Kopf M., Stamenkovic I. et al., 2009. PloS one, 4 (8) pp. e6510. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D931E988C46C]
Sequence conservation in Plasmodium falciparum alpha-helical coiled coil domains proposed for vaccine development.
Kulangara C., Kajava A.V., Corradin G., Felger I., 2009. PloS one, 4 (5) pp. e5419. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_10CC6346EDDE]
The C-terminal domain of Plasmodium falciparum merozoite surface protein 3 self-assembles into alpha-helical coiled coil tetramer.
Gondeau C., Corradin G., Heitz F., Le Peuch C., Balbo A., Schuck P., Kajava A.V., 2009. Molecular and biochemical parasitology, 165 (2) pp. 153-161. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BF22736E33A7]
 
The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity.
Bongfen S.E., Ntsama P.M., Offner S., Smith T., Felger I., Tanner M., Alonso P., Nebie I., Romero J.F., Silvie O. et al., 2009. Vaccine, 27 (2) pp. 328-335. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E31ACCD055B5]
The synthetic Plasmodium falciparum circumsporozoite peptide PfCS102 as a malaria vaccine candidate: a randomized controlled phase I trial.
Audran Regine, Lurati-Ruiz Floriana, Genton Blaise, Blythman Hildur E., Ofori-Anyinam Opokua, Reymond Christophe, Corradin Giampietro, Spertini Francois, 2009. PloS One, 4 (10) p. 7304. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8A01928CCC8F]
 
Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage-associated Plasmodium falciparum protein PFF0165c.
Olugbile S., Kulangara C., Bang G., Bertholet S., Suzarte E., Villard V., Frank G., Audran R., Razaname A., Nebie I. et al., 2009. Infection and immunity, 77 (12) pp. 5701-5709. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_76FF93700FF4]
2008
 
Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria?
Nebie I., Tiono A.B., Diallo D.A., Samandoulougou S., Diarra A., Konate A.T., Cuzin-Ouattara N., Theisen M., Corradin G., Cousens S. et al., 2008. Tropical medicine & international health, 13 (2) pp. 229-237. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5EA446D4ACD3]
 
Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya
Agak G. W., Bejon P., Fegan G., Gicheru N., Villard V., Kajava A. V., Marsh K., Corradin G., 2008. Vaccine, 26 (16) pp. 1963-1971. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FD137A3AFF2B]
 
Oxidative folding of synthetic polypeptides S-protected as tert-butylthio derivatives.
Verdini A., Terenzi S., Brossard V., Roggero M., Corradin G., 2008. Journal of Peptide Science, 14 (12) pp. 1271-1282.
[DOI][WoS][Pmid][serval:BIB_66012B0C9B23]
 
Processing of the circumsporozoite protein in infected hepatocytes is not dependent on aspartic proteases
Bongfen S. E., Balam S., Torgler R., Romero J. F., Corradin G., 2008. Parasite Immunology, 30 (6-7) pp. 375-378. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_987DE5FC2CFF]
 
Sporozoite-mediated hepatocyte wounding limits Plasmodium parasite development via MyD88-mediated NF-kappa B activation and inducible NO synthase expression
Torgler R., Bongfen S. E., Romero J. C., Tardivel A., Thome M., Corradin G., 2008. Journal of Immunology, 180 (6) pp. 3990-3999. Peer-reviewed.
[WoS][Pmid][serval:BIB_E1DD33F82039]
 
Sustained activation and tumor targeting of NKT cells using a CD1d-anti-HER2-scFv fusion protein induce antitumor effects in mice
Stirnemann K., Romero J. F., Baldi L., Robert B., Cesson V., Besra G. S., Zauderer M., Wurm F., Corradin G., Mach J. P. et al., 2008. Journal of Clinical Investigation, 118 (3) pp. 994-1005. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_485E2DDD51B5]
2007
 
IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations
Romero J. F., Ibrahim G. H., Renggli J., Himmelrich H., Graber P., Corradin G., 2007/11. Parasite Immunology, 29 (11) pp. 541-8.
[DOI][WoS][Pmid][serval:BIB_DDB1A7367C33]
 
Plasmodium berghei-infected primary hepatocytes process and present the circumsporozoite protein to specific CD8+ T cells in vitro
Bongfen S. E., Torgler R., Romero J. F., Renia L., Corradin G., 2007/06. Journal of Immunology, 178 (11) pp. 7054-63.
[WoS][Pmid][serval:BIB_D6899D4AD196]
 
Plasmodium vivax thrombospondin related adhesion protein: immunogenicity and protective efficacy in rodents and Aotus monkeys
Castellanos A., Arevalo-Herrera M., Restrepo N., Gulloso L., Corradin G., Herrera S., 2007/06. Memorias do Instituto Oswaldo Cruz, 102 (3) pp. 411-6.
[WoS][Pmid][serval:BIB_D92A17622536]
 
Peptide based malaria vaccine development: personal considerations
Corradin G., 2007/05. Microbes and Infection, 9 (6) pp. 767-71.
[DOI][WoS][Pmid][serval:BIB_E2969EFF211F]
 
Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial
Hermsen C. C., Verhage D. F., Telgt D. S., Teelen K., Bousema J. T., Roestenberg M., Bolad A., Berzins K., Corradin G., Leroy O. et al., 2007/04. Vaccine, 25 (15) pp. 2930-40.
[DOI][WoS][Pmid][serval:BIB_D7D3BB6645DA]
 
An update on the search for a Plasmodium vivax vaccine
Herrera S., Corradin G., Arevalo-Herrera M., 2007/03. Trends in Parasitology, 23 (3) pp. 122-8.
[DOI][WoS][Pmid][serval:BIB_B742D5E848CE]
 
Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice
Mata E., Carcaboso A. M., Hernandez R. M., Igartua M., Corradin G., Pedraz J. L., 2007/01. Vaccine, 25 (5) pp. 877-85.
[DOI][WoS][Pmid][serval:BIB_1BF14D51B8E5]
Rapid identification of malaria vaccine candidates based on alpha-helical coiled coil protein motif.
Villard V., Agak G.W., Frank G., Jafarshad A., Servis C., Nébié I., Sirima S.B., Felger I., Arevalo-Herrera M., Herrera S. et al., 2007. Plos One, 2 (7) pp. e645.
[URN][DOI][WoS][Pmid][serval:BIB_8ED3445AE0F0]
2006
 
Cross-presentation of a human malaria CTL epitope is conformation dependent
Prato S., Fleming J., Schmidt C. W., Corradin G., Lopez J. A., 2006/05. Molecular Immunology, 43 (13) pp. 2031-6.
[DOI][WoS][Pmid][serval:BIB_29A363A11BCE]
 
Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Cesson V., Stirnemann K., Robert B., Luescher I., Filleron T., Corradin G., Mach J.P., Donda A., 2006. Clinical cancer research, 12 (24) pp. 7422-7430. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_37C143EC404D]
 
Synthetic RGD-containing alpha-helical coiled coil peptides promote integrin-dependent cell adhesion.
Villard V., Kalyuzhniy O., Riccio O., Potekhin S., Melnik T.N., Kajava A.V., Rüegg C., Corradin G., 2006. Journal of Peptide Science, 12 (3) pp. 206-212. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6D785D120087]
2005
 
Biodegradable microspheres alone do not stimulate murine macrophages in vitro, but prolong antigen presentation by macrophages in vitro and stimulate a solid immune response in mice.
Luzardo-Alvarez A., Blarer N., Peter K., Romero J.F., Reymond C., Corradin G., Gander B., 2005/12. Journal of Controlled Release, 109 (1-3) pp. 62-76. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_962198CD5738]
 
Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen
Audran R., Cachat M., Lurati F., Soe S., Leroy O., Corradin G., Druilhe P., Spertini F., 2005/12. Infection and Immunity, 73 (12) pp. 8017-26.
[DOI][WoS][Pmid][serval:BIB_FE3CF85509B0]
 
Safety and elicitation of humoral and cellular responses in colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccine
Herrera S., Bonelo A., Perlaza B. L., Fernandez O. L., Victoria L., Lenis A. M., Soto L., Hurtado H., Acuna L. M., Velez J. D. et al., 2005/11. American Journal of Tropical Medicine and Hygiène, 73 (5 Suppl) pp. 3-9.
[WoS][Pmid][serval:BIB_DBCADD330106]
 
A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites
Meraldi V., Romero J. F., Kensil C., Corradin G., 2005/04. Vaccine, 23 (21) pp. 2801-12.
[DOI][WoS][Pmid][serval:BIB_CB0ECD7D5E0A]
 
MHC class I-restricted exogenous presentation of a synthetic 102-mer malaria vaccine polypeptide
Prato S., Maxwell T., Pinzon-Charry A., Schmidt C. W., Corradin G., Lopez J. A., 2005/03. European Journal of Immunology, 35 (3) pp. 681-9.
[DOI][WoS][Pmid][serval:BIB_BD214ADB2463]
 
Plasmodium falciparum merozoite surface protein 6 displays multiple targets for naturally occurring antibodies that mediate monocyte-dependent parasite killing
Singh S., Soe S., Roussilhon C., Corradin G., Druilhe P., 2005/02. Infection and Immunity, 73 (2) pp. 1235-8.
[DOI][WoS][Pmid][serval:BIB_FE00C0459D25]
A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum.
Druilhe P., Spertini F., Soesoe D., Corradin G., Mejia P., Singh S., Audran R., Bouzidi A., Oeuvray C., Roussilhon C., 2005. PLoS Medicine, 2 (11) pp. e344. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_59DEE9BC1555]
2004
 
Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite protein
Herrera S., Bonelo A., Perlaza B. L., Valencia A. Z., Cifuentes C., Hurtado S., Quintero G., Lopez J. A., Corradin G., Arevalo-Herrera M., 2004/12. International Journal for Parasitology, 34 (13-14) pp. 1535-46.
[DOI][WoS][Pmid][serval:BIB_ECE8EA6314FE]
 
Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF
Sedegah M., Charoenvit Y., Aguiar J., Sacci J., Hedstrom R., Kumar S., Belmonte A., Lanar D. E., Jones T. R., Abot E. et al., 2004/11. Genes Immun, 5 (7) pp. 553-61.
[DOI][WoS][Pmid][serval:BIB_32641F8662E6]
Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design
Singh S., Soe S., Mejia J. P., Roussilhon C., Theisen M., Corradin G., Druilhe P., 2004/09. Journal of Infectious Diseases, 190 (5) pp. 1010-8.
[URN][DOI][WoS][Pmid][serval:BIB_CAC01C95C9AF]
 
Update on the clinical development of candidate malaria vaccines
Ballou W. R., Arevalo-Herrera M., Carucci D., Richie T. L., Corradin G., Diggs C., Druilhe P., Giersing B. K., Saul A., Heppner D. G. et al., 2004/08. American Journal of Tropical Medicine and Hygiène, 71 (2 Suppl) pp. 239-47.
[WoS][Pmid][serval:BIB_8BB1A4BA3311]
 
Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection
Meraldi V., Nebie I., Tiono A. B., Diallo D., Sanogo E., Theisen M., Druilhe P., Corradin G., Moret R., Sirima B. S., 2004/07. Parasite Immunology, 26 (6-7) pp. 265-72.
[DOI][WoS][Pmid][serval:BIB_A2A4A99A281C]
 
Organization of designed nanofibrils assembled from alpha-helical peptides as determined by electron microscopy.
Kajava A.V., Potekhin S.A., Corradin G., Leapman R.D., 2004/05. Journal of Peptide Science, 10 (5) pp. 291-297. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AE3D33A58E6D]
 
Intranasal treatment with ovalbumin but not the major T cell epitope ovalbumin 323-339 generates interleukin-10 secreting T cells and results in the induction of allergen systemic tolerance
Barbey C., Donatelli-Dufour N., Batard P., Corradin G., Spertini F., 2004/04. Clinical and Experimental Allergy, 34 (4) pp. 654-62.
[DOI][WoS][Pmid][serval:BIB_04B00977F039]
 
Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions.
Peyre M., Audran R., Estevez F., Corradin G., Gander B., Sesardic D., Johansen P., 2004. Journal of Controlled Release, 99 (3) pp. 345-355. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E27E742A8A3D]
 
Medicinal application of long synthetic peptide technology.
Corradin G., Spertini F., Verdini A., 2004. Expert opinion on biological therapy, 4 (10) pp. 1629-39.
[DOI][WoS][Pmid][serval:BIB_D8A7EF59A754]
2003
Shift of fibril-forming ability of the designed alpha-helical coiled-coil peptides into the physiological pH region
Melnik T. N., Villard V., Vasiliev V., Corradin G., Kajava A. V., Potekhin S. A., 2003/12. Protein Engineering, 16 (12) pp. 1125-30.
[URN][DOI][WoS][Pmid][serval:BIB_F4229622AB4C]
 
Humoral responses to defined malaria antigens in children living since birth under insecticide treated curtains in Burkina Faso
Nebie I., Cuzin-Ouattara N., Diallo D. A., Cousens S. N., Theisen M., Corradin G., Traore A. S., Esposito F., 2003/09. Acta Tropica, 88 (1) pp. 17-25.
[DOI][WoS][Pmid][serval:BIB_FF5F491A9DF5]
 
OM-174, a new adjuvant with a potential for human use, induces a protective response when administered with the synthetic C-terminal fragment 242-310 from the circumsporozoite protein of Plasmodium berghei
Meraldi V., Audran R., Romero J. F., Brossard V., Bauer J., Lopez J. A., Corradin G., 2003/06. Vaccine, 21 (19-20) pp. 2485-91.
[DOI][WoS][Pmid][serval:BIB_8FB8D9C81247]
 
Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial
Fellrath J. M., Kettner A., Dufour N., Frigerio C., Schneeberger D., Leimgruber A., Corradin G., Spertini F., 2003/04. Journal of Allergy and Clinical Immunology, 111 (4) pp. 854-61.
[DOI][WoS][Pmid][serval:BIB_21E9AA87DCBA]
 
Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro
Audran R., Peter K., Dannull J., Men Y., Scandella E., Groettrup M., Gander B., Corradin G., 2003/03. Vaccine, 21 (11-12) pp. 1250-5.
[DOI][WoS][Pmid][serval:BIB_EF0B0D971D04]
 
In vivo targeting of an anti-tumor antibody coupled to antigenic MHC class I complexes induces specific growth inhibition and regression of established syngeneic tumor grafts.
Donda A., Cesson V., Mach J.P., Corradin G., Primus F.J., Robert B., 2003. Cancer Immunity, 3 p. 11.
[Pmid][serval:BIB_7767EE02583B]
2002
 
Novel peptide inhibitors of Leishmania gp63 based on the cleavage site of MARCKS (myristoylated alanine-rich C kinase substrate)-related protein
Corradin S., Ransijn A., Corradin G., Bouvier J., Delgado M. B., Fernandez-Carneado J., Mottram J. C., Vergeres G., Mauel J., 2002/11. Biochemical Journal, 367 (3) pp. 761-769.
[DOI][WoS][Pmid][serval:BIB_70EA24CBA206]
 
Malaria vaccines: from the laboratory to the field.
Genton B., Corradin G., 2002/10. Current Drug Targets. Immune, Endocrine and Metabolic Disorders, 2 (3) pp. 255-267.
[Pmid][serval:BIB_2D9C9B7EA36A]
 
IL-12 administration leads to a transient depletion of T cells, B cells, and APCs and concomitant abrogation of the HLA-A2.1-restricted CTL response in transgenic mice
Peter K., Brunda M. J., Corradin G., 2002/07. Journal of Immunology, 169 (1) pp. 63-7.
[WoS][Pmid][serval:BIB_7047F2763046]
 
Identification of HLA-A2 restricted CD8(+) T-lymphocyte responses to Plasmodium vivax circumsporozoite protein in individuals naturally exposed to malaria
Arevalo-Herrera M., Valencia A. Z., Vergara J., Bonelo A., Fleischhauer K., Gonzalez J. M., Restrepo J. C., Lopez J. A., Valmori D., Corradin G. et al., 2002/03. Parasite Immunology, 24 (3) pp. 161-9.
[DOI][WoS][Pmid][serval:BIB_EFE6EE22ADEF]
 
In vivo kinetics of the immunoglobulin E response to allergen: bystander effect of coimmunization and relationship with anaphylaxis
Von Garnier C., Astori M., Kettner A., Dufour N., Corradin G., Spertini F., 2002/03. Clinical and Experimental Allergy, 32 (3) pp. 401-10.
[DOI][WoS][Pmid][serval:BIB_554162D1626A]
 
Recognition of synthetic polypeptides corresponding to the N- and C-terminal fragments of Plasmodium falciparum Exp-1 by T-cells and plasma from human donors from African endemic areas
Meraldi V., Nebie I., Moret R., Cuzin-Ouattara N., Thiocone A., Doumbo O., Esposito F., Traore A. S., Corradin G., Terenzi S., 2002/03. Parasite Immunology, 24 (3) pp. 141-50.
[DOI][WoS][Pmid][serval:BIB_A26543FF329A]
 
Assessment of antigen-specific CTL- and CD8(+)-dependent IFN-gamma responses in mice
Peter K., Audran R., Bonelo A., Corradin G., Lopez J. A., 2002. Methods in Molecular Medicine, 72 pp. 437-44.
[DOI][Pmid][serval:BIB_56C41DC113A8]
 
Peptide vaccination
Meraldi V., Romero J. F., Corradin G., 2002. Methods in Molecular Medicine, 72 pp. 335-45.
[DOI][Pmid][serval:BIB_76E2FB296DA7]
2001
 
De novo design of fibrils made of short alpha-helical coiled coil peptides
Potekhin S. A., Melnik T. N., Popov V., Lanina N. F., Vazina A. A., Rigler P., Verdini A. S., Corradin G., Kajava A. V., 2001/11. Chemistry and Biology, 8 (11) pp. 1025-32.
[DOI][WoS][Pmid][serval:BIB_B865900D4E20]
 
Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity
Theisen M., Dodoo D., Toure-Balde A., Soe S., Corradin G., Koram K. K., Kurtzhals J. A., Hviid L., Theander T., Akanmori B. et al., 2001/09. Infection and Immunity, 69 (9) pp. 5223-9.
[DOI][WoS][Pmid][serval:BIB_BBFFBB1CFC43]
 
A synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies
Lopez J. A., Weilenman C., Audran R., Roggero M. A., Bonelo A., Tiercy J. M., Spertini F., Corradin G., 2001/07. European Journal of Immunology, 31 (7) pp. 1989-98.
[WoS][Pmid][serval:BIB_F82E98AA87F9]
 
Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants
Peter K., Men Y., Pantaleo G., Gander B., Corradin G., 2001/07. Vaccine, 19 (30) pp. 4121-9.
[DOI][WoS][Pmid][serval:BIB_347FD9650034]
 
Long synthetic peptides encompassing the Plasmodium falciparum LSA3 are the target of human B and T cells and are potent inducers of B helper, T helper and cytolytic T cell responses in mice
Perlaza B. L., Sauzet J. P., Balde A. T., Brahimi K., Tall A., Corradin G., Druilhe P., 2001/07. European Journal of Immunology, 31 (7) pp. 2200-9.
[DOI][WoS][Pmid][serval:BIB_8E484C6BD7C3]
 
Api m 6: a new bee venom allergen
Kettner A., Hughes G. J., Frutiger S., Astori M., Roggero M., Spertini F., Corradin G., 2001/05. Journal of Allergy and Clinical Immunology, 107 (5) pp. 914-20.
[DOI][WoS][Pmid][serval:BIB_A96274CCCC85]
 
CD1d-restricted NK T cells are dispensable for specific antibody responses and protective immunity against liver stage malaria infection in mice.
Romero J.F., Eberl G., MacDonald H.R., Corradin G., 2001. Parasite immunology, 23 (5) pp. 267-269. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4834517088A2]
2000
 
Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres
Johansen P., Estevez F., Zurbriggen R., Merkle H. P., Gluck R., Corradin G., Gander B., 2000/12. Vaccine, 19 (9-10) pp. 1047-54.
[DOI][WoS][Pmid][serval:BIB_0A2A71D9F681]
 
Generation and characterization of malaria-specific human CD8(+) lymphocyte clones: effect of natural polymorphism on T cell recognition and endogenous cognate antigen presentationby liver cells
Bonelo A., Valmori D., Triponez F., Tiercy J. M., Mentha G., Oberholzer J., Champagne P., Romero J. F., Esposito F., Nebie I. et al., 2000/11. European Journal of Immunology, 30 (11) pp. 3079-88.
[DOI][WoS][Pmid][serval:BIB_514D2CAAC142]
 
HLA-A*0201 restricted CD8+ T-lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN-gamma ELISPOT
Gonzalez J. M., Peter K., Esposito F., Nebie I., Tiercy J. M., Bonelo A., Arevalo-Herrera M., Valmori D., Romero P., Herrera S. et al., 2000/10. Parasite Immunology, 22 (10) pp. 501-14.
[DOI][WoS][Pmid][serval:BIB_9F7B229DBD6C]
 
Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice
Astori M., von Garnier C., Kettner A., Dufour N., Corradin G., Spertini F., 2000/09. Journal of Immunology, 165 (6) pp. 3497-505.
[WoS][Pmid][serval:BIB_8AB432488550]
 
The synthetic, oxidized C-terminal fragment of the Plasmodium berghei circumsporozoite protein elicits a high protective response
Roggero M. A., Meraldi V., Lopez J. A., Eberl G., Romero J. C., Matile H., Betschart B., Corradin G., Renggli J., 2000/09. European Journal of Immunology, 30 (9) pp. 2679-85.
[DOI][WoS][Pmid][serval:BIB_F3219D5448D2]
 
A subdominant CD8(+) cytotoxic T lymphocyte (CTL) epitope from the Plasmodium yoelii circumsporozoite protein induces CTLs that eliminate infected hepatocytes from culture
Franke E. D., Sette A., Sacci, J., Jr. , Southwood S., Corradin G., Hoffman S. L., 2000/06. Infection and Immunity, 68 (6) pp. 3403-11.
[DOI][WoS][Pmid][serval:BIB_1F26A122295F]
 
Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis
von Garnier C., Astori M., Kettner A., Dufour N., Heusser C., Corradin G., Spertini F., 2000/06. European Journal of Immunology, 30 (6) pp. 1638-45.
[DOI][WoS][Pmid][serval:BIB_556A085642B9]
 
Highly stable oligomerization forms of HIV-1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV-1 LTR
Tosi G., Meazza R., De Lerma Barbaro A., D'Agostino A., Mazza S., Corradin G., Albini A., Noonan D. M., Ferrini S., Accolla R. S., 2000/04. European Journal of Immunology, 30 (4) pp. 1120-6.
[DOI][WoS][Pmid][serval:BIB_A908FE3742B5]
1999
 
CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein
Charoenvit Y., Majam V. F., Corradin G., Sacci, J. B., Jr. , Wang R., Doolan D. L., Jones T. R., Abot E., Patarroyo M. E., Guzman F. et al., 1999/11. Infection and Immunity, 67 (11) pp. 5604-14.
[WoS][Pmid][serval:BIB_42D44A62CC5F]
 
Interethnic differences in the humoral response to non-repetitive regions of the Plasmodium falciparum circumsporozoite protein
Modiano D., Chiucchiuini A., Petrarca V., Sirima B. S., Luoni G., Roggero M. A., Corradin G., Coluzzi M., Esposito F., 1999/10. American Journal of Tropical Medicine and Hygiène, 61 (4) pp. 663-7.
[WoS][Pmid][serval:BIB_E4B16CD441BE]
 
Plasmodium falciparum CS C-terminal fragment: preclinical evaluation and phase I clinical studies
Roggero M. A., Weilenmann C., Bonelo A., Audran R., Renggli J., Spertini F., Corradin G., Lopez J. A., 1999/09. Parassitologia, 41 (1-3) pp. 421-4.
[Pmid][serval:BIB_0E665AE0E84D]
 
IgE and T-cell responses to high-molecular weight allergens from bee venom
Kettner A., Henry H., Hughes G. J., Corradin G., Spertini F., 1999/03. Clinical and Experimental Allergy, 29 (3) pp. 394-401.
[WoS][Pmid][serval:BIB_BF6142B7D415]
 
MHC class I- and class II-restricted processing and presentation of microencapsulated antigens
Men Y., Audran R., Thomasin C., Eberl G., Demotz S., Merkle H. P., Gander B., Corradin G., 1999/03. Vaccine, 17 (9-10) pp. 1047-56.
[DOI][WoS][Pmid][serval:BIB_4F9346B18E04]
 
Extracellular processing and presentation of a 69-mer synthetic polypetide to MHC class I-restricted T cells
Eberl G., Renggli J., Men Y., Roggero M. A., Lopez J. A., Corradin G., 1999/02. Molecular Immunology, 36 (2) pp. 103-12.
[DOI][WoS][Pmid][serval:BIB_93BF3674813C]
 
Induction in transgenic mice of HLA-A2.1-restricted cytotoxic T cells specific for a peptide sequence from a mutated p21ras protein.
Escobar P., Yu Z., Terskikh A., Holmes N., Corradin G., Mach J.P., Healy F., 1999. Clinical and Experimental Immunology, 116 (2) pp. 214-219.
[WoS][Pmid][serval:BIB_0E2952B38E91]
 
Lymphocyte response to tetanus toxin T-cell epitopes: effects of tetanus vaccination and concurrent malaria prophylaxis
Fryauff D. J., Mouzin E., Church L. W., Ratiwayanto S., Hadiputranto H., Sutamihardja M. A., Widjaja H., Corradin G., Subianto B., Hoffman S. L., 1999/01. Vaccine, 17 (1) pp. 59-63.
[DOI][WoS][Pmid][serval:BIB_1CF6B45F03FD]
MARCKS-related protein (MRP) is a substrate for the Leishmania major surface protease leishmanolysin (gp63).
Corradin S., Ransijn A., Corradin G., Roggero M.A., Schmitz A.A., Schneider P., Mauël J., Vergères G., 1999. Journal of Biological Chemistry, 274 (36) pp. 25411-25418.
[URN][DOI][WoS][Pmid][serval:BIB_09CCF8818B94]
 
The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis.
Solioz N., Blum-Tirouvanziam U., Jacquet R., Rafati S., Corradin G., Mauël J., Fasel N., 1999. Vaccine, 18 (9-10) pp. 850-859.
[DOI][WoS][Pmid][serval:BIB_31AFF7AE0546]
1998
 
Release of tetanus toxoid from adjuvants and PLGA microspheres: how experimental set-up and surface adsorption fool the pattern.
Johansen P., Corradin G., Merkle H.P., Gander B., 1998/12. Journal of Controlled Release : Official Journal of the Controlled Release Society, 56 (1-3) pp. 209-217. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3657A43CC45F]
 
Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents
Audran R., Men Y., Johansen P., Gander B., Corradin G., 1998/07. Pharmaceutical Research, 15 (7) pp. 1111-6.
[DOI][WoS][Pmid][serval:BIB_DAE8D7E9E478]
 
Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives
Johansen P., Men Y., Audran R., Corradin G., Merkle H. P., Gander B., 1998/07. Pharmaceutical Research, 15 (7) pp. 1103-10.
[DOI][WoS][Pmid][serval:BIB_731E034526DE]
 
Mapping and comparison of the B-cell epitopes recognized on the Plasmodium vivax circumsporozoite protein by immune Colombians and immunized Aotus monkeys
Arevalo-Herrera M., Roggero M. A., Gonzalez J. M., Vergara J., Corradin G., Lopez J. A., Herrera S., 1998/07. Annals of Tropical Medicine and Parasitology, 92 (5) pp. 539-51.
[DOI][WoS][Pmid][serval:BIB_4543F7333940]
 
Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants
Le T. P., Church L. W., Corradin G., Hunter R. L., Charoenvit Y., Wang R., de la Vega P., Sacci J., Ballou W. R., Kolodny N. et al., 1998/02. Vaccine, 16 (2-3) pp. 305-12.
[DOI][WoS][Pmid][serval:BIB_64390243D094]
 
An anti-CD19 antibody coupled to a tetanus toxin peptide induces efficient Fas ligand (FasL)-mediated cytotoxicity of a transformed human B cell line by specific CD4+ T cells.
Eberl G., Jiang S., Yu Z., Schneider P., Corradin G., Mach J.P., 1998. Clinical and Experimental Immunology, 114 (2) pp. 173-178. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_703F4655F900]
1997
 
Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection
Marussig M., Renia L., Motard A., Miltgen F., Petour P., Chauhan V., Corradin G., Mazier D., 1997/12. International Immunology, 9 (12) pp. 1817-24.
[DOI][WoS][Pmid][serval:BIB_64B017D69763]
 
Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides
Franke E. D., Corradin G., Hoffman S. L., 1997/10. Journal of Immunology, 159 (7) pp. 3424-33.
[WoS][Pmid][serval:BIB_D928FB04DC66]
 
Delineation of PLA2 epitopes using short or long overlapping synthetic peptides: interest for specific immunotherapy
Kammerer R., Kettner A., Chvatchko Y., Dufour N., Tiercy J. M., Corradin G., Spertini F., 1997/09. Clinical and Experimental Allergy, 27 (9) pp. 1016-26.
[DOI][WoS][Pmid][serval:BIB_A4B24540D65A]
 
Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres
Men Y., Tamber H., Audran R., Gander B., Corradin G., 1997/09. Vaccine, 15 (12-13) pp. 1405-12.
[DOI][WoS][Pmid][serval:BIB_47DF33DCE046]
 
Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes
Charoenvit Y., Fallarme V., Rogers W. O., Sacci, J. B., Jr. , Kaur M., Aguiar J. C., Yuan L. F., Corradin G., Andersen E., Wizel B. et al., 1997/08. Infection and Immunity, 65 (8) pp. 3430-7.
[WoS][Pmid][serval:BIB_13BCC50E5FFD]
 
Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides
Toujas L., Delcros J. G., Diez E., Gervois N., Semana G., Corradin G., Jotereau F., 1997/08. Immunology, 91 (4) pp. 635-42.
[DOI][WoS][Pmid][serval:BIB_A3BA9478AA10]
 
Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy
Kammerer R., Chvatchko Y., Kettner A., Dufour N., Corradin G., Spertini F., 1997/07. Journal of Allergy and Clinical Immunology, 100 (1) pp. 96-103.
[WoS][Pmid][serval:BIB_F16DE225564F]
 
Peptide-MHC complexes assembled following multiple pathways: an opportunity for the design of vaccines and therapeutic molecules
Corradin G., Demotz S., 1997/05. Human Immunology, 54 (2) pp. 137-47.
[DOI][WoS][Pmid][serval:BIB_14C4D758922E]
 
Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing P. vivax CS epitopes in Aotus monkeys
Herrera S., De Plata C., Gonzalez M., Perlaza B. L., Bettens F., Corradin G., Arevalo-Herrera M., 1997/04. Parasite Immunology, 19 (4) pp. 161-70.
[DOI][WoS][Pmid][serval:BIB_36FA8B4EB308]
 
Synthetic polypeptides corresponding to the non-repeat regions from the circumsporozoite protein of Plasmodium falciparum: recognition by human T-cells and immunogenicity in owl monkeys
Lopez J. A., Gonzalez J. M., Kettner A., Arevalo-Herrera M., Herrera S., Corradin G., Roggero M. A., 1997/04. Annals of Tropical Medicine and Parasitology, 91 (3) pp. 253-65.
[WoS][Pmid][serval:BIB_269AABBC31BF]
 
Cytotoxic T lymphocyte responses to wild-type and mutant mouse p53 peptides
Bertholet S., Iggo R., Corradin G., 1997/03. European Journal of Immunology, 27 (3) pp. 798-801.
[DOI][WoS][Pmid][serval:BIB_D110C49D9369]
 
Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity
Renggli J., Hahne M., Matile H., Betschart B., Tschopp J., Corradin G., 1997/03. Parasite Immunology, 19 (3) pp. 145-8.
[DOI][WoS][Pmid][serval:BIB_EB6CC497F191]
 
A simple and rapid procedure for the purification of synthetic polypeptides by a combination of affinity chromatography and methionine chemistry.
Roggero M.A., Servis C., Corradin G., 1997. Febs Letters, 408 (3) pp. 285-288.
[DOI][WoS][Pmid][serval:BIB_9F431BC0DC4C]
1996
 
Immunodominance of cytotoxic T lymphocyte epitopes co-injected in vivo and modulation by interleukin-12
Eberl G., Kessler B., Eberl L. P., Brunda M. J., Valmori D., Corradin G., 1996/11. European Journal of Immunology, 26 (11) pp. 2709-16.
[DOI][WoS][Pmid][serval:BIB_1EF12E5F58AD]
 
Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes
Wang R., Charoenvit Y., Corradin G., De La Vega P., Franke E. D., Hoffman S. L., 1996/11. Journal of Immunology, 157 (9) pp. 4061-7.
[WoS][Pmid][serval:BIB_B6407E9CF346]
 
Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine
Wang R., Charoenvit Y., Daly T. M., Long C. A., Corradin G., Hoffman S. L., 1996/11. Immunology Letters, 53 (2-3) pp. 83-93.
[DOI][WoS][Pmid][serval:BIB_B9551F5B7A0D]
 
Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres
Men Y., Gander B., Merkle H. P., Corradin G., 1996/10. Vaccine, 14 (15) pp. 1442-50.
[WoS][Pmid][serval:BIB_FD16B9FF12F1]
 
Recognition of synthetic 104-mer and 102-mer peptides corresponding to N- and C-terminal nonrepeat regions of the Plasmodium falciparum circumsporozoite protein by sera from human donors
Lopez J. A., Roggero M. A., Duombo O., Gonzalez J. M., Tolle R., Koita O., Arevalo-Herrera M., Herrera S., Corradin G., 1996/10. American Journal of Tropical Medicine and Hygiène, 55 (4) pp. 424-9.
[WoS][Pmid][serval:BIB_9C9F7E9F3E04]
 
The functional half-life of H-2Kd-restricted T cell epitopes on living cells
Eberl G., Widmann C., Corradin G., 1996/09. European Journal of Immunology, 26 (9) pp. 1993-9.
[DOI][WoS][Pmid][serval:BIB_5AA790F8FBF1]
 
Peptide immunization in humans: a combined CD8+/CD4+ T cell-targeted vaccine restimulates the memory CD4 T cell response but fails to induce cytotoxic T lymphocytes (CTL)
Brander C., Corradin G., Hasler T., Pichler W. J., 1996/07. Clinical and Experimental Immunology, 105 (1) pp. 18-25.
[DOI][WoS][Pmid][serval:BIB_FBCC85EA6567]
 
Specific tolerization of active cytolytic T lymphocyte responses in vivo with soluble peptides
Duarte E. A., Eberl G., Corradin G., 1996/04. Cellular Immunology, 169 (1) pp. 16-23.
[DOI][WoS][Pmid][serval:BIB_A7383A0BF272]
1995
 
Induction of protective polyclonal antibodies by immunization with Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine
Wang R., Charoenvit Y., Corradin G., Porrozzi R., Hunter R. L., Glenn G., Alving C. R., Church P., Hoffman S. L., 1995/08. Journal of Immunology, 155 (3) p. 1637.
[Pmid][serval:BIB_DAB8A9512756]
 
Identification of HIV protein-derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as synthetic vaccine
Brander C., Pichler W. J., Corradin G., 1995/07. Clinical and Experimental Immunology, 101 (1) pp. 107-13.
[WoS][Pmid][serval:BIB_F35047B86D21]
 
A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide
Men Y., Thomasin C., Merkle H. P., Gander B., Corradin G., 1995/05. Vaccine, 13 (7) pp. 683-9.
[WoS][Pmid][serval:BIB_568CACF30B5C]
 
CD8+ T-cell protective immunity induced by immunization with Plasmodium berghei CS protein-derived synthetic peptides: evidence that localization of peptide-specific CTLs is crucial for protection against malaria
Renggli J., Valmori D., Romero J. F., Eberl G., Romero P., Betschart B., Corradin G., 1995/05. Immunology Letters, 46 (1-2) pp. 199-205.
[DOI][WoS][Pmid][serval:BIB_7B5E6AD78B7A]
 
Identification of a nonameric H-2Kk-restricted CD8+ cytotoxic T lymphocyte epitope on the Plasmodium falciparum circumsporozoite protein
Malik A., Houghten R., Corradin G., Buus S., Berzofsky J. A., Hoffman S. L., 1995/05. Infection and Immunity, 63 (5) pp. 1955-9.
[WoS][Pmid][serval:BIB_78D618FCD9BF]
 
Strong similarities in antigen fine specificity among DRB1* 1302-restricted tetanus toxin tt830-843-specific TCRs in spite of highly heterogeneous CDR3
Boitel B., Blank U., Mege D., Corradin G., Sidney J., Sette A., Acuto O., 1995/04. Journal of Immunology, 154 (7) pp. 3245-55.
[WoS][Pmid][serval:BIB_3547AA98E23B]
 
Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine
Wang R., Charoenvit Y., Corradin G., Porrozzi R., Hunter R. L., Glenn G., Alving C. R., Church P., Hoffman S. L., 1995/03. Journal of Immunology, 154 (6) pp. 2784-93.
[WoS][Pmid][serval:BIB_1C771A22964E]
 
A simple mathematical model for the functional peptide/MHC/TCR interactions
Eberl G., Roggero M. A., Corradin G., 1995/01. Journal of Immunology, 154 (1) pp. 219-25.
[WoS][Pmid][serval:BIB_B034A57BB749]
 
Anchoring of an immunogenic Plasmodium falciparum circumsporozoite protein on the surface of Dictyostelium discoideum.
Reymond C.D., Beghdadi-Rais C., Roggero M., Duarte E.A., Desponds C., Bernard M., Groux D., Matile H., Bron C., Corradin G. et al., 1995. Journal of Biological Chemistry, 270 (21) pp. 12941-12947.
[DOI][WoS][Pmid][serval:BIB_345099EB55B9]
 
Antigen-processing organelles from DRB1*1101 and DRB1*1104 B cell lines display a differential degradation activity
Barbey C., Watts C., Corradin G., 1995/01. European Journal of Immunology, 25 (1) pp. 30-6.
[DOI][WoS][Pmid][serval:BIB_BFF429BDD8CB]
 
Cellular immunology of tetanus toxoid
Corradin G., Watts C., 1995. Current Topics in Microbiology and Immunology, 195 pp. 77-87.
[WoS][Pmid][serval:BIB_5A0D4BEDFCCC]
 
Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum.
Blum-Tirouvanziam U., Servis C., Habluetzel A., Valmori D., Men Y., Esposito F., Del Nero L., Holmes N., Fasel N., Corradin G., 1995. Journal of Immunology, 154 (8) pp. 3922-3931.
[WoS][Pmid][serval:BIB_AA72CA2FD058]
 
Synthesis and immunological characterization of 104-mer and 102-mer peptides corresponding to the N- and C-terminal regions of the Plasmodium falciparum CS protein.
Roggero M.A., Filippi B., Church P., Hoffman S.L., Blum-Tirouvanziam U., Lopez J.A., Esposito F., Matile H., Reymond C.D., Fasel N. et al., 1995. Molecular Immunology, 32 (17-18) pp. 1301-1309.
[DOI][WoS][Pmid][serval:BIB_DF6578240513]
1994
 
Biologically addressable monolayer structures formed by templates of sulfur-bearing molecules
Duschl C., Liley M., Corradin G., Vogel H., 1994/09. Biophysical Journal, 67 (3) pp. 1229-37.
[DOI][WoS][Pmid][serval:BIB_4631FC389BDC]
 
Induction of a cytotoxic T cell response by co-injection of a T helper peptide and a cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): further enhancement by pre-injection of IFA alone
Valmori D., Romero J. F., Men Y., Maryanski J. L., Romero P., Corradin G., 1994/06. European Journal of Immunology, 24 (6) pp. 1458-62.
[DOI][WoS][Pmid][serval:BIB_0C485DA437E0]
 
Functional analysis of two tetanus toxin universal T cell epitopes in their interaction with DR1101 and DR1104 alleles
Valmori D., Sabbatini A., Lanzavecchia A., Corradin G., Matricardi P. M., 1994/03. Journal of Immunology, 152 (6) pp. 2921-9.
[WoS][Pmid][serval:BIB_1D50C339E57D]
 
Processing and presentation of tetanus toxin by antigen-presenting cells from patients with chronic granulomatous disease (CGD) to human specific T cell clones are not impaired
Barbey C., Tiercy J. M., Fairweather N., Niemann H., Seger R., Corradin G., 1994/02. Clinical and Experimental Immunology, 95 (2) pp. 227-31.
[WoS][Pmid][serval:BIB_DA13657D064C]
 
Elicitation of specific cytotoxic T cells by immunization with malaria soluble synthetic polypeptides.
Blum-Tirouvanziam U., Beghdadi-Rais C., Roggero M.A., Valmori D., Bertholet S., Bron C., Fasel N., Corradin G., 1994. Journal of Immunology, 153 (9) pp. 4134-4141.
[WoS][Pmid][serval:BIB_C014428D5942]
 
Immunogenicity of multiple antigen peptides containing Plasmodium vivax CS epitopes in BALB/c mice
Herrera M. A., de Plata C., Gonzalez J. M., Corradin G., Herrera S., 1994. Memorias do Instituto Oswaldo Cruz, 89 Suppl 2 pp. 71-6.
[WoS][Pmid][serval:BIB_BF74D42C981E]
 
Peptide-antibody conjugates for tumour therapy: a MHC-class-II-restricted tetanus toxin peptide coupled to an anti-Ig light chain antibody can induce cytotoxic lysis of a human B-cell lymphoma by specific CD4 T cells.
Yu Z., Healy F., Valmori D., Escobar P., Corradin G., Mach J.P., 1994. International Journal of Cancer, 56 (2) pp. 244-248.
[DOI][WoS][Pmid][serval:BIB_DE3F7FE5CAD5]
1993
 
MHC class I H-2Kd-restricted antigenic peptides: additional constraints for the binding motif
Eberl G., Sabbatini A., Servis C., Romero P., Maryanski J. L., Corradin G., 1993/11. International Immunology, 5 (11) pp. 1489-92.
[DOI][WoS][Pmid][serval:BIB_1DE733391E98]
 
Presentation of T-cell epitopes assembled as multiple-antigen peptides to murine and human T lymphocytes
Grillot D., Valmori D., Lambert P. H., Corradin G., Del Giudice G., 1993/07. Infection and Immunity, 61 (7) pp. 3064-7.
[WoS][Pmid][serval:BIB_61F3D5725757]
 
The interaction of antigenic peptides with the H-2Kd MHC class I molecule
Maryanski J. L., Luthy R., Romero P., Healy F., Drouet C., Casanova J. L., Jaulin C., Kourilsky P., Corradin G., 1993/04. Seminars in Immunology, 5 (2) pp. 95-104.
[DOI][Pmid][serval:BIB_6E8F2EBF1064]
 
Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages
Renia L., Grillot D., Marussig M., Corradin G., Miltgen F., Lambert P. H., Mazier D., Del Giudice G., 1993/02. Journal of Immunology, 150 (4) pp. 1471-8.
[WoS][Pmid][serval:BIB_447C2F5F7CC1]
 
Malaria vaccine: immunization of mice with a synthetic T cell helper epitope alone leads to protective immunity
Migliorini P., Betschart B., Corradin G., 1993/02. European Journal of Immunology, 23 (2) pp. 582-5.
[DOI][WoS][Pmid][serval:BIB_6690A9336337]
 
The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86
Demotz S., Barbey C., Corradin G., Amoroso A., Lanzavecchia A., 1993/02. European Journal of Immunology, 23 (2) pp. 425-32.
[DOI][WoS][Pmid][serval:BIB_192E780AD740]
1992
 
T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides
Widmann C., Romero P., Maryanski J. L., Corradin G., Valmori D., 1992/10. Journal of Immunological Methods, 155 (1) pp. 95-9.
[DOI][WoS][Pmid][serval:BIB_694E7A2EBDAF]
 
Total chemical synthesis, characterization, and immunological properties of an MHC class I model using the TASP concept for protein de novo design
Tuchscherer G., Servis C., Corradin G., Blum U., Rivier J., Mutter M., 1992/10. Protein Science, 1 (10) pp. 1377-86.
[DOI][WoS][Pmid][serval:BIB_50CB74C58DCF]
 
Monoclonal antibodies recognize a processing dependent epitope present in the mature CS protein of various plasmodial species
Tsuji M., Corradin G., Zavala F., 1992/09. Parasite Immunology, 14 (5) pp. 457-69.
[DOI][WoS][Pmid][serval:BIB_AA8456BD5301]
 
Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide
Lethe B., van den Eynde B., van Pel A., Corradin G., Boon T., 1992/09. European Journal of Immunology, 22 (9) pp. 2283-8.
[DOI][WoS][Pmid][serval:BIB_7EED9A346ECD]
 
In vitro immune recognition of synthetic peptides from the Plasmodium falciparum CS protein by individuals naturally exposed to different sporozoite challenge
Esposito F., Lombardi S., Modiano D., Habluetzel A., Del Nero L., Lamizana L., Pietra V., Rotigliano G., Corradin G., Ravot E. et al., 1992/07. Immunology Letters, 33 (2) pp. 187-99.
[DOI][WoS][Pmid][serval:BIB_2F0770261F31]
 
Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination
Valmori D., Pessi A., Bianchi E., Corradin G., 1992/07. Journal of Immunology, 149 (2) pp. 717-21.
[WoS][Pmid][serval:BIB_84361EDD8FC3]
 
Human recognition of T cell epitopes on the Plasmodium vivax circumsporozoite protein
Herrera S., Escobar P., de Plata C., Avila G. I., Corradin G., Herrera M. A., 1992/06. Journal of Immunology, 148 (12) pp. 3986-90.
[WoS][Pmid][serval:BIB_A8963C6BFA36]
 
Dictyostelium discoideum as an expression host for the circumsporozoite protein of Plasmodium falciparum.
Fasel N., Begdadi-Rais C., Bernard M., Bron C., Corradin G., Reymond C.D., 1992. Gene, 111 (2) pp. 157-163.
[DOI][WoS][Pmid][serval:BIB_0645695131F1]
 
Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. Evidence that two peptide residues are buried in the MHC molecule.
Romero P., Eberl G., Casanova J.L., Cordey A.S., Widmann C., Luescher I.F., Corradin G., Maryanski J.L., 1992. Journal of immunology, 148 (6) pp. 1871-1878. Peer-reviewed.
[WoS][Pmid][serval:BIB_33DDB9CF7602]
1991
 
Differential stability of antigenic MHC class I-restricted synthetic peptides
Widmann C., Maryanski J. L., Romero P., Corradin G., 1991/12. Journal of Immunology, 147 (11) pp. 3745-51.
[WoS][Pmid][serval:BIB_4712D317BB0B]
 
NMR studies of an oligoproline-containing peptide analogue that binds specifically to the H-2Kd histocompatibility molecule
Boulat B., Emsley L., Muller N., Corradin G., Maryanski J. L., Bodenhausen G., 1991/10. Biochemistry, 30 (39) pp. 9429-34.
[DOI][WoS][Pmid][serval:BIB_1AA4EF601EA1]
The identification of tyrosine as a common key residue in unrelated H-2Kd restricted antigenic peptides
Maryanski J. L., Romero P., Van Pel A., Boon T., Salemme F. R., Cerottini J. C., Corradin G., 1991/10. International Immunology, 3 (10) pp. 1035-42.
[URN][DOI][WoS][Pmid][serval:BIB_B9764698CBB6]
 
Characterization of murine monoclonal antibodies against a repetitive synthetic peptide from the circumsporozoite protein of the human malaria parasite, Plasmodium falciparum
Del Giudice G., Tougne C., Renia L., Ponnudurai T., Corradin G., Pessi A., Verdini A. S., Louis J. A., Mazier D., Lambert P. H., 1991/09. Molecular Immunology, 28 (9) pp. 1003-9.
[DOI][WoS][Pmid][serval:BIB_338A865FC38F]
 
In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide
Renia L., Marussig M. S., Grillot D., Pied S., Corradin G., Miltgen F., Del Giudice G., Mazier D., 1991/09. Proceedings of the National Academy of Sciences of the United States of America, 88 (18) pp. 7963-7.
[DOI][WoS][Pmid][serval:BIB_B8670D15F269]
 
Lack of H-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide
Pessi A., Valmori D., Migliorini P., Tougne C., Bianchi E., Lambert P. H., Corradin G., Del Giudice G., 1991/09. European Journal of Immunology, 21 (9) pp. 2273-6.
[DOI][WoS][Pmid][serval:BIB_70A5555302F3]
CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria
Rodrigues M. M., Cordey A. S., Arreaza G., Corradin G., Romero P., Maryanski J. L., Nussenzweig R. S., Zavala F., 1991/06. International Immunology, 3 (6) pp. 579-85.
[URN][DOI][WoS][Pmid][serval:BIB_D54952DB1643]
 
Recognition by class II alloreactive T cells of processed determinants from human serum proteins
Panina-Bordignon P., Corradin G., Roosnek E., Sette A., Lanzavecchia A., 1991/06. Science, 252 (5012) pp. 1548-50.
[DOI][WoS][Pmid][serval:BIB_4EED122DAF50]
 
Macrophage NO2- production as a sensitive and rapid assay for the quantitation of murine IFN-gamma
Migliorini P., Corradin G., Corradin S. B., 1991/05. Journal of Immunological Methods, 139 (1) pp. 107-14.
[DOI][WoS][Pmid][serval:BIB_7D66274FA483]
H-2Kd-restricted antigenic peptides share a simple binding motif.
Romero P., Corradin G., Luescher I.F., Maryanski J.L., 1991. The Journal of experimental medicine, 174 (3) pp. 603-612. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4B1396F22BA8]
1990
 
Antigen processing and presentation
Corradin G., 1990/08. Immunology Letters, 25 (1-3) pp. 11-3.
[DOI][WoS][Pmid][serval:BIB_13E37BB61F58]
 
Hepatic phase of malaria is the target of cellular mechanisms induced by the previous and the subsequent stages. A crucial role for liver nonparenchymal cells
Mazier D., Renia L., Nussler A., Pied S., Marussig M., Goma J., Grillot D., Miltgen F., Drapier J. C., Corradin G. et al., 1990/08. Immunology Letters, 25 (1-3) pp. 65-70.
[DOI][WoS][Pmid][serval:BIB_8A3FA6EBACF4]
 
Isolation and characterization of protective cytolytic T cells in a rodent malaria model system
Romero P., Maryanski J. L., Cordey A. S., Corradin G., Nussenzweig R. S., Zavala F., 1990/08. Immunology Letters, 25 (1-3) pp. 27-31.
[DOI][WoS][Pmid][serval:BIB_CEA1B3FF4CC9]
 
Peptide-primed CD4+ cells and malaria sporozoites
Del Giudice G., Grillot D., Renia L., Muller I., Corradin G., Louis J. A., Mazier D., Lambert P. H., 1990/08. Immunology Letters, 25 (1-3) pp. 59-63.
[DOI][WoS][Pmid][serval:BIB_E49A991A834F]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University